Open-label, Randomized, Single-dose, Placebo-controlled, 4-way Crossover Study to Investigate the Pharmacokinetic Interaction of Glycopyrrolate and Formoterol in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2015
At a glance
- Drugs Glycopyrrolate (Primary) ; Formoterol
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Acronyms TRIPLE 1
- Sponsors Chiesi Farmaceutici SpA
- 02 Apr 2012 Actual end date (Aug 2011 ) added as reported by ClinicalTrials.gov.
- 02 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2011 New trial record